Helus Pharma Inc. Insider Ownership | HELP

Insider Holdings by Owner

9.63Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

27.68%

Shares Held by Insiders

9.63Mn

filed for Sep 2026

Shares Outstanding

34.80Mn

34,802,943 shares

Direct Holdings

9.63Mn

Indirect: 3.00K

Net Open-Market Trades

+788.00K

net bought · $9.67Mn in Sep 2026

Insiders Holding Shares

4

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Oct 21, 2026

Over the past year, HELP insiders bought $8.42 million of stock (688K shares) on the open market and sold none.

A count shows 4 insiders buying HELP stock on the open market over the past 12 months and none selling.
Among Helus Pharma insiders, Eric H. L. So (Executive Chair) led open-market buying over the past 12 months with $3.57 million of purchases (295K shares); the latest was on September 8, 2026.
The newest open-market trade among Helus Pharma insiders came on September 29, 2026, when Greg Cavers (Chief Financial Officer) made a purchase of 3K shares for $38,730.
Outside the open market, Helus Pharma insiders received 248K shares in stock awards over the past 12 months.
Per Business Quant data, Helus Pharma insiders hold 9.63Mn shares in total based on their latest Form 4 filings, or 27.68% of the 34.8Mn shares outstanding.
By type of ownership, HELP insiders hold 99.97% of their shares directly (9.63Mn shares) and 0.03% indirectly (3K shares).
Business Quant counts 4 insiders with holdings in Helus Pharma stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
HELP's three largest insider shareholders, per their latest Form 4 filings, are Paul Glavine (Chief Growth Officer, 4.75Mn shares), Eric H. L. So (Director, 4.71Mn shares) and Michael Halstead (Chief Executive Officer, 168.57K shares).
The largest insider, Paul Glavine, holds 49.30% of HELP's insider total.
Over the past 12 months, 4 insiders reported transactions in Helus Pharma stock in 11 Form 4 filings.
Insider figures for HELP include Form 4 filings through October 1, 2026.

Form 4 Holdings

Insiders Holding HELP

Insiders 4

Shares held 9.63Mn

Of outstanding 27.68%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Paul Glavine	Chief Growth Officer	4,750,191	0	4,750,191	49.3%	01 Oct, 2026
2	Eric H. L. So	Director	4,713,014	0	4,713,014	48.9%	01 Oct, 2026
3	Michael Halstead	Chief Executive Officer	168,568	0	168,568	1.7%	21 Sep, 2026
4	Greg Cavers	Chief Financial Officer	0	3,000	3,000	0.0%	01 Oct, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

11 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
29 Sep, 2026	Greg Cavers	Chief Financial Officer	Acquired P	3,000	$12.91	$38.73K	3,000	Indirect
30 Sep, 2026	Eric H. L. So	Director	Acquired A	248,000	—	—	4,713,014	Direct
30 Sep, 2026	Paul Glavine	Chief Growth Officer	Acquired A	248,000	—	—	4,750,191	Direct
21 Sep, 2026	Michael Halstead	Chief Executive Officer	Acquired P	100,000	$13.47	$1.35Mn	168,568	Direct
08 Sep, 2026	Paul Glavine	Chief Growth Officer	Acquired P	100,000	$12.47	$1.25Mn	4,271,252	Direct
08 Sep, 2026	Eric H. L. So	Executive Chair	Acquired P	100,000	$12.39	$1.24Mn	4,465,014	Direct
08 Sep, 2026	Paul Glavine	Chief Growth Officer	Acquired P	100,000	$12.47	$1.25Mn	4,271,252	Direct
31 Aug, 2026	Paul Glavine	Chief Growth Officer	Acquired P	90,000	$11.59	$1.04Mn	4,071,252	Direct
01 Sep, 2026	Eric H. L. So	Executive Chair	Acquired P	95,000	$11.81	$1.12Mn	4,265,014	Direct
03 Sep, 2026	Paul Glavine	Chief Growth Officer	Acquired P	100,000	$11.78	$1.18Mn	4,171,252	Direct
04 Sep, 2026	Eric H. L. So	Executive Chair	Acquired P	100,000	$12.09	$1.21Mn	4,365,014	Direct

Helus Pharma HELP Insider Ownership